Detalhe da pesquisa
1.
Epigenetic regulation during cancer transitions across 11 tumour types.
Nature
; 623(7986): 432-441, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37914932
2.
Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V'DJer.
Bioinformatics
; 32(24): 3729-3734, 2016 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27559159
3.
Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription.
Genome Res
; 22(2): 259-70, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22086061
4.
Therapy Sequencing in Patients With Advanced Neuroendocrine Neoplasms.
Am Soc Clin Oncol Educ Book
; 43: e389278, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-37257140
5.
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN).
NPJ Breast Cancer
; 9(1): 1, 2023 Jan 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36609389
6.
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages.
bioRxiv
; 2023 Nov 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37961519
7.
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer.
Nat Genet
; 54(9): 1390-1405, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35995947
8.
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.
Cell Rep
; 24(6): 1434-1444.e7, 2018 08 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30089255
9.
Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.
J Clin Invest
; 127(9): 3472-3483, 2017 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28825599
10.
Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types.
J Natl Cancer Inst
; 108(11)2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27335052
11.
Claudin-low bladder tumors are immune infiltrated and actively immune suppressed.
JCI Insight
; 1(3): e85902, 2016 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-27699256
12.
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.
J Clin Oncol
; 34(6): 542-9, 2016 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-26527775
13.
Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.
Clin Cancer Res
; 20(14): 3818-29, 2014 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24916698